Replies to post #13125 on Biotech Values

[DewDiligence]

>>Estimated timeline for this device & SRDX?<<

There isn’t any development timeline yet that one can rely on because SRDX’s in-house trials with I-vation are essentially proof-of-concept. What happens next will depend on which drug companies (if any) are interested in licensing the platform.

[DewDiligence]

Re: SRDX

Biowatch et al: this post from six months ago may refresh your memory about the device that SRDX is now calling I-vation: #msg-5165296.